ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	15/143	120/7206	1.1113492198e-08
ko04621	NOD-like receptor signaling pathway	13/143	157/7206	1.25836781131e-05
ko04380	Osteoclast differentiation	11/143	134/7206	6.52121760957e-05
ko05134	Legionellosis	8/143	74/7206	9.86621748308e-05
ko05164	Influenza A	12/143	167/7206	0.000110654790881
ko05132	Salmonella infection	9/143	98/7206	0.000130292938052
ko05131	Shigellosis	8/143	82/7206	0.000204174488229
ko04974	Protein digestion and absorption	8/143	96/7206	0.00060165485037
ko04210	Apoptosis	11/143	180/7206	0.000859112319853
ko04510	Focal adhesion	13/143	240/7206	0.000915767845441
ko04512	ECM-receptor interaction	7/143	79/7206	0.000920672675023
ko04932	Non-alcoholic fatty liver disease (NAFLD)	11/143	182/7206	0.000941206820863
ko04657	IL-17 signaling pathway	7/143	87/7206	0.00162720650065
ko05133	Pertussis	7/143	87/7206	0.00162720650065
ko04662	B cell receptor signaling pathway	7/143	88/7206	0.00173903564733
ko04920	Adipocytokine signaling pathway	7/143	89/7206	0.00185675441077
ko05120	Epithelial cell signaling in Helicobacter pylori infection	7/143	92/7206	0.00224734343049
ko04064	NF-kappa B signaling pathway	7/143	96/7206	0.00286352706713
ko04660	T cell receptor signaling pathway	8/143	124/7206	0.00313874797712
ko04620	Toll-like receptor signaling pathway	7/143	100/7206	0.00360183648812
ko04611	Platelet activation	9/143	163/7206	0.00499027398729
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/143	135/7206	0.00526470033633
ko05168	Herpes simplex infection	9/143	182/7206	0.0100515769825
ko04666	Fc gamma R-mediated phagocytosis	7/143	122/7206	0.0105240923556
ko05160	Hepatitis C	8/143	153/7206	0.0109228496491
ko05145	Toxoplasmosis	7/143	126/7206	0.0124296437071
ko05100	Bacterial invasion of epithelial cells	6/143	99/7206	0.0136156353481
ko04215	Apoptosis - multiple species	4/143	47/7206	0.0137026889228
ko05410	Hypertrophic cardiomyopathy (HCM)	6/143	100/7206	0.0142548139986
ko05142	Chagas disease (American trypanosomiasis)	7/143	130/7206	0.0145728904771
ko05219	Bladder cancer	4/143	48/7206	0.0147234727992
ko04115	p53 signaling pathway	5/143	74/7206	0.0154577297443
ko04624	Toll and Imd signaling pathway	4/143	49/7206	0.015791165008
ko05130	Pathogenic Escherichia coli infection	5/143	77/7206	0.0180906708508
ko04931	Insulin resistance	7/143	137/7206	0.0189396536831
ko04610	Complement and coagulation cascades	5/143	79/7206	0.0200013972163
ko05161	Hepatitis B	8/143	173/7206	0.0214812076385
ko05321	Inflammatory bowel disease (IBD)	4/143	56/7206	0.0246269194799
ko05210	Colorectal cancer	5/143	86/7206	0.0277144233207
ko04670	Leukocyte transendothelial migration	7/143	151/7206	0.0302837210076
ko05323	Rheumatoid arthritis	5/143	89/7206	0.0315271087141
ko00254	Aflatoxin biosynthesis	1/143	2/7206	0.0392980404374
ko00660	C5-Branched dibasic acid metabolism	1/143	2/7206	0.0392980404374
ko04658	Th1 and Th2 cell differentiation	5/143	96/7206	0.041654570244
ko05146	Amoebiasis	5/143	99/7206	0.0465333358561
ko04530	Tight junction	9/143	228/7206	0.0468241095342
ko04630	Jak-STAT signaling pathway	6/143	132/7206	0.0470773354331
ko04623	Cytosolic DNA-sensing pathway	3/143	41/7206	0.0471536139495
ko04068	FoxO signaling pathway	7/143	167/7206	0.048030359124